Endometrial Neoplasms: all 1,347 studies

Page 7 of 14. Open to participants first (452), then studies with results posted, then the rest; newest registration first within each.

• Lapatinib in Treating Patients With Recurrent or Persistent Endometrial CancerCompletedNCT00096447Phase 2Results posted
• Ixabepilone in Treating Patients With Recurrent or Persistent Endometrial CancerCompletedNCT00095979Phase 2Results posted
• RAD001 in Recurrent Endometrial Cancer PatientsCompletedNCT00087685Phase 2Results posted
• Temsirolimus in Treating Patients With Metastatic or Locally Advanced Recurrent Endometrial CancerCompletedNCT00072176Phase 2Results posted
• Doxorubicin Hydrochloride, Cisplatin, and Paclitaxel or Carboplatin and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrial CancerCompletedNCT00063999Phase 3Results posted
• Cervical Cytology DNA Methylation for Endometrial Cancer ScreeningActive, not recruitingNCT07874529
• PEG-rhG-CSF Primary Prophylaxis vs Therapeutic Short-Acting rhG-CSF for Neutropenia During Pelvic Chemoradiotherapy in Cervical or Endometrial CancerActive, not recruitingNCT07865650Not applicable
• Robotic vs Laparoscopic and Open Surgery for Abdominopelvic CancersCompletedNCT07821775
• Advancing Risk Stratification in Endometrial CancerActive, not recruitingNCT07746024
• Comparison of Lee-Huang Point and Umbilical Entry for Laparoscopic Success in Endometrial Cancer PatientsCompletedNCT07725159Not applicable
• ctDNA Assessment in Endometrial Cancer for Adjuvant TherapyActive, not recruitingNCT07681414
• Endometrial Cancer Vaginal Fluid Specimen Collection StudyActive, not recruitingNCT07544680
• Impact of Molecular Pathological And Clinical Features for Adjuvant Treatment Selection in Endometrial Cancer: Asian RegistryActive, not recruitingNCT07354087
• Comparison Between High and Low Level Para-aortic Lymphadenectomy in High and Intermediate Risk Endometrial CarcinomaCompletedNCT07306195Not applicable
• Activity and Cancer Survivorship Exercise PilotActive, not recruitingNCT07283029Not applicable
• ONSD as an ICP Marker in vNOTES and TLHCompletedNCT07250178Not applicable
• Virtual Mental Health Intervention to Address Fear of Progression for Women With High Risk or Stage III-IV Gynecologic or Breast CancerWithdrawnNCT07226102Not applicable
• Serum Trace Element Levels in Some Gynecological DiseasesCompletedNCT07210918Not applicable
• Taste Alteration, Sarcopenia, and Malnutrition in Gynecologic Cancer Patients Receiving Carboplatin-Paclitaxel ChemotherapyCompletedNCT07154966
• AssociatiNG Bevacizumab bEmarituzumab for GynecoLogIcal CAncerWithdrawnNCT07146919Phase 1/2
• Effect of Metformin on Endometrial Thickness in Postmenopausal Breast Cancer Patients Receiving TamoxifenCompletedNCT07145827Not applicable
• Hugo™ Robotic-Assisted Surgery (RAS) System in Gynecological Subjects (Embrace Gynecology)Active, not recruitingNCT07120945Not applicable
• Glove Compression for Chemotherapy-Induced NeuropathyCompletedNCT07105553Not applicable
• A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K MutationsActive, not recruitingNCT07038369Phase 1
• A Study to Evaluate ARV-806 in Adults With Advanced Cancer That Has the KRAS G12D MutationActive, not recruitingNCT07023731Phase 1/2
• Tumor-Infiltrating Lymphocytes in Endometrial CancerCompletedNCT06976333
• ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid TumorsCompletedNCT06973161
• Radiomics and Molecular Classification in Endometrial CancerActive, not recruitingNCT06963385Not applicable
• Sexual Health Integration in Treatment of Gynecological OncologyCompletedNCT06958068
• A Study to Investigate the Prevalence of Human Epidermal Growth Factor Receptor 2 (HER2) Immunohistochemistry (IHC) 3+ and Characterize the Clinicopathologic Features of Gynecologic Cancers in TaiwanCompletedNCT06925113
• Weight Loss Management in Endometrial Cancer SurvivorsActive, not recruitingNCT06877572
• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Efficacy and Indications of RP903CompletedNCT06846099Phase 1
• Methylated Biomarkers Predictive of Endometrial Cancer RiskActive, not recruitingNCT06800677
• Endometrial Carcinoma: Comparison of Surgical Approaches (Laparoscopy vs Laparotomy)Active, not recruitingNCT06790004
• Validation Study on the Removal of EpCAM-positive Tumour Cells From Blood Collected During Tumour Surgery Using Catumaxomab/Catuvab DeviceCompletedNCT06789224Not applicable
• A Study of a Weight Loss Intervention in People With Endometrial CancerActive, not recruitingNCT06751589Early Phase 1
• A Study to Evaluate the Use of Durvalumab in Combination With Platinum-based Chemotherapy Followed by Durvalumab With Olaparib as First-line Treatment in Advanced or Recurrent Endometrial Cancer in SpainActive, not recruitingNCT06746116Phase 3
• Enhanced Recovery After Surgery (ERAS) for Laparoscopic Hysterectomy at Low Risk Endometrial CancerCompletedNCT06732635Phase 3
• Evaluate BL-M17D1 in Patients w/HER2-Expressing/Mutant Advanced or Metastatic Solid TumorsTerminatedNCT06714617Phase 1
• A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Effectiveness of GSK4418959 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid TumorsActive, not recruitingNCT06710847Phase 1/2
• A Study of ASP1893 in Adults With Advanced CLDN6-positive Solid TumorsWithdrawnNCT06681870Phase 1
• Single-Port Hysterectomy (R-SPH) Using the Da Vinci SP System in Low-Risk Endometrial CancerCompletedNCT06681831Not applicable
• GYNecologic Cancer-Related COGnitive ImpairmentCompletedNCT06662435Not applicable
• First-in-Human Study of ATX-559, an Oral Inhibitor of DHX9, in Patients With Advanced or Metastatic Solid Tumors, and Molecularly Defined CancersTerminatedNCT06625515Phase 1
• Strain-elastography in Endometrial CancerCompletedNCT06623916
• Improved Early Diagnosis in Female Pelvic Cancer With OC DetectCompletedNCT06613230
• A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid TumorsActive, not recruitingNCT06607185Phase 1
• Efficacy Assessment of Lenvatinib Associated with Pembrolizumab in Metastatic Endometrial Cancer: a French Multicentric Retrospective Early Access Program-based StudyCompletedNCT06599463
• Clinical Trial Protocol to Evaluate the Efficacy and Safety of Laparoscopic Surgical Systems for Gynaecological SurgeryActive, not recruitingNCT06598085Not applicable
• Molecular Classification of Endometrial Cancer: Impact on Adjuvant Treatment Planning.Active, not recruitingNCT06584630
• Evaluating the Anticancer Learning Circle Lifestyle Program in Endometrial Cancer SurvivorsCompletedNCT06550791Not applicable
• Strive Cardio for Endometrial Cancer SurvivorsCompletedNCT06534008Not applicable
• A Study to Learn About Study Medicine ALTA2618 in Adults With AKT1 E17K-Mutant Solid TumorsActive, not recruitingNCT06533059Phase 1
• Virtual Reality's Role in See&Treat HysteroscopyCompletedNCT06524934Not applicable
• Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Participants With Endometrial Cancer After Platinum-Based Chemotherapy and Immunotherapy (ASCENT-GYN-01/GOG-3104/ENGOT-en26)Active, not recruitingNCT06486441Phase 3
• Diet, Hepcidin, and Chemotherapy RDIActive, not recruitingNCT06483997
• Endometrial Cell Collection With the PadKitCompletedNCT06464107Not applicable
• A Study of PHN-010 in Patients With Advanced Solid TumorsTerminatedNCT06457997Phase 1
• POSE - POs Surgery Endometrial CancerCompletedNCT06394258Not applicable
• Efficacy and Safety Study of Lurbinectedin and Dostarlimab in Cancer Patients: Protocol VHIO21001 - LiDerWithdrawnNCT06385548Phase 1/2
• ASk Questions in GYnecologic Oncology (ASQ-GYO)CompletedNCT06339827Not applicable
• BAT1308 in Combination With Platinum-containing Chemotherapy is Used for the First-line Treatment of Advanced or Recurrent dMMR Endometrial CancerTerminatedNCT06321068Phase 2/3
• A Study of Dostarlimab in Combination With Carboplatin-paclitaxel in Japanese Participants With Primary Advanced or Recurrent Endometrial CancerActive, not recruitingNCT06317311Phase 2
• Effect of Physical Activity Intervention on Overweight and Obese Patients With Endometrial CancerCompletedNCT06312917Not applicable
• NM32-2668 in Adult Patients With Selected Advanced Solid TumorsTerminatedNCT06299163Phase 1
• Performance of Ultrasound in Women With Postmenopausal or Abnormal Uterine Bleeding Between White and Black Ethnic Groups- a Retrospective Cohort Study.Active, not recruitingNCT06293066
• A Study With NKT3447 for Adults With Advanced/Metastatic Solid TumorsTerminatedNCT06264921Phase 1
• A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage TumorsActive, not recruitingNCT06257264Phase 1
• Development of a Molecular Diagnostic Tool for Endometrial Cancer.CompletedNCT06192017
• Suspension of the Pelvic and Abdominal Organs During Minimally Invasive SurgeryCompletedNCT06187558
• Choices About Genetic Testing And Learning Your Risk With Smart TechnologyCompletedNCT06184867Not applicable
• Neo-adjuvant Pembrolizumab as an Alternative Treatment for MMRd Uterine CancerActive, not recruitingNCT06180733Phase 2
• Mobile Weight Loss Intervention for Adolescent and Young Adult Cancer SurvivorsCompletedNCT06171945Not applicable
• PRO1107 in Patients With Advanced Solid TumorsTerminatedNCT06171789Phase 1/2
• Immunohistochemistry Role in Better Prognosis of Endometrial Carcinoma PatientsCompletedNCT06148129Not applicable
• Sacituzumab Tirumotecan (MK-2870) in Post Platinum and Post Immunotherapy Endometrial Cancer (MK-2870-005)Active, not recruitingNCT06132958Phase 3
• Pilot Window of Opportunity Trial (POET)Active, not recruitingNCT06129604Phase 2
• Endometrial Tissues and Mononuclear Cells Receptivity in Pathogenesis of Endometrial Proliferative ProcessesCompletedNCT06115577
• Combination Chemotherapy of Paclitaxel and Carboplatin With or Without Anthracycline as Aneo Adjuvant Treatment in Advanced Endometrial CarcinomaCompletedNCT06102252Not applicable
• Iron Prehabilitation in Endometrial CancerCompletedNCT06049693Phase 4
• GEN1046 in Combination With Anticancer Agents for the Treatment of Advanced Endometrial CancerWithdrawnNCT06046274Phase 2
• Study of Favezelimab Coformulated With Pembrolizumab (MK-4280A) in Participants With Selected Solid Tumors (MK-4280A-010)CompletedNCT06036836Phase 2
• Molecular and Epidemiological Characteristics of Endometrial Cancer in BrazilCompletedNCT06014580
• Prevention and Treatment of CINV Caused by TC Regimen in Gynecological Malignant Tumor PatientsCompletedNCT06007586Phase 3
• A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2Active, not recruitingNCT06003231Phase 2
• Endometrial Malignancy in Breast Cancer Patients With or Without AUBCompletedNCT05977829
• A Study of NPX267 for Subjects With Solid Tumors Known to Express HHLA2/B7-H7SuspendedNCT05958199Phase 1
• Expression Analysis of the COPB 2 and Bcl-2 in Early Stages of Endometrial CarcinomaCompletedNCT05951426
• Patient Reported Outcomes Study Using Electronic Monitoring System for Advanced or Metastatic Solid CancerActive, not recruitingNCT05931445Not applicable
• Investigation Of Receptivity Markers For Endometrial Cancer Treatment DevelopmentCompletedNCT05914844
• Study and Transformation of Tumor Molecular Features Screening Model of Endometrial Carcinoma Surgical ApproachStatus unknownNCT05894915Not applicable
• A Biomarker Screening Protocol for Participants With Solid TumorsTerminatedNCT05891197
• Practice Patterns Among Gynecologic Oncologists on Tumor Genetic Testing in Endometrial CancerTerminatedNCT05877404
• Online Adaptive Radiotherapy for Postoperative Treatment of Endometrial and Cervical CancerActive, not recruitingNCT05869123Phase 1/2
• Safety, PK and Efficacy of AI-061 in Advanced Solid TumorsCompletedNCT05858736Phase 1
• Quality of Life Assessment of Radiotherapy in Recurrent Head and Neck CancerWithdrawnNCT05850663Not applicable
• Study of Cadonilimab (AK104) Plus Lenvatinib in Patients With Advanced Endometrial CancerActive, not recruitingNCT05824481Phase 2
• A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Cervical and Endometrial CancerStatus unknownNCT05812677Early Phase 1
• Safety of RAD301 in Healthy Human Volunteers and Patients With Pancreatic Cancer or Other Solid TumorsActive, not recruitingNCT05799274Phase 1
• Study of ART0380 in Patients With Biologically Selected Solid TumorsTerminatedNCT05798611Phase 2

← Endometrial Neoplasms overview